mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |